Trial intelligence / Profile preview

Clinical evaluation of dried blood spots for tamoxifen and endoxifen measurement

NL-OMON26648Withdrawn

Sponsor
Slotervaartziekenhuis
Start
Nov 2012
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of tamoxifen and z-endoxifen in breast cancer, sponsored by Slotervaartziekenhuis. Planned start Nov 2012; status: withdrawn.

02

Drugs

tamoxifenz-endoxifen
03

Conditions

breast cancer

Beyond the preview

Go deeper on NL-OMON26648.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON26648.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call